Navigation

    Forum

    • Register
    • Login
    • Search
    • Categories
    • Recent
    • Popular
    • Users
    • Groups

    RWE Committee Update

    Newsletters/Blogs
    external rwe timeline committee
    1
    2
    793
    Loading More Posts
    • Oldest to Newest
    • Newest to Oldest
    • Most Votes
    Reply
    • Reply as topic
    Log in to reply
    This topic has been deleted. Only users with topic management privileges can see it.
    • Jennifer Carroll
      Jennifer Carroll last edited by Jennifer Carroll

      Good Afternoon @Agency and @Manufacturer

      UPDATE:

      The RWE Committee has completed the draft guidance and it is now available upon request for external feedback. If your organization would like to provide feedback, please coordinate a point person to reach out to Pauline Dong (paulined@paab.ca) and myself (jenniferc@paab.ca) to acquire the draft document to collect feedback from your organization. We ask that all feedback be collated into a single response provided prior to the consultation deadline.

      The consultation period will be from March 13th through to April 3rd. This consultation period was selected with the understanding that this guidance


      In November of 2022, PAAB struck a committee to generate a framework for acceptance of Real-World Evidence (RWE) in healthcare professional advertising. While the framework will focus on evidentiary standards and disclosure criteria pertaining to RWE, it will set the stage for guidance pertaining to other forms of evidence which don’t meet evidentiary gold standards but have value to clinical practice. The committee is dedicated to ensuring the framework promotes the use of RWE in advertising in a manner that is truthful, transparent, trustworthy, and in the best interest of all Canadians who rely on informed healthcare professionals.

      The committee consists of industry experts from manufacturers and agencies.

      Amyn Sayani Ph.D.

      Director, Medical Evidence
      Scientific Affairs
      AstraZeneca Canada

      Chrysanthy Christopoulous

      Medical Advisor and Strategist
      Lemieux Bedard

      Jefferson Tea

      Vice-President, Medical & Scientific Affairs
      Takeda

      Matt Slipek

      Sr Planner, Strategic Planning
      Havas

      Manushvi Gupta Regulatory Manager Reckitt Nina Hemery

      Medical Advisor
      Fisika

      Virginie Giroux

      Director of HEOR
      Merck

      PAAB:

      Patrick Massad - Commissioner
      Pauline Dong - Director of Policy
      Jennifer Carroll - Director of Communications

      As the committee finalizes the draft document, we will head to industry consultation and consultation with healthcare professionals.
      588fabd0-0294-4972-a0d7-c453fe3af703-image.png

      Please stay tuned for further development and updates along the development timeline. If you have any questions or comments, please post them in the chat below.

      Jennifer Carroll 1 Reply Last reply Reply Quote 1
      • Jennifer Carroll
        Jennifer Carroll @Jennifer Carroll last edited by

        @Agency and @Manufacturer - Please see update above

        1 Reply Last reply Reply Quote 0
        • First post
          Last post